Centrient Pharmaceuticals
Centrient Pharmaceuticals, a leading name in pharmaceutical preparation manufacturing, is headquartered in the Netherlands and operates across key regions in Europe, Asia, and North America. Founded in 2017, the company has quickly established itself as a significant player in the industry, focusing on the development and production of essential antibiotics and anti-infectives.
Centrient's core offerings include a range of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms, distinguished by their commitment to sustainability and innovation. The company is recognised for its advanced manufacturing processes and dedication to meeting global health needs, positioning itself as a trusted partner in the pharmaceutical supply chain. With a strong emphasis on quality and compliance, Centrient Pharmaceuticals continues to achieve notable milestones, reinforcing its market position as a reliable provider of critical healthcare solutions.
+33 vs industry average
Centrient Pharmaceuticals’s score of 71 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Centrient Pharmaceuticals?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2028
Reported emissions
Scope 3 accounts for ••• of total emissions.
Centrient Pharmaceuticals's reported carbon emissions
Centrient Pharmaceuticals, a company in the Pharmaceutical Preparation Manufacturing industry headquartered in the Netherlands, has reported significant greenhouse gas (GHG) emissions. In 2025, the company's total calculated emissions were approximately 601.8 million kg CO2e. This figure comprises approximately 101.5 million kg CO2e from Scope 1 (direct emissions), approximately 148.0 million kg CO2e from Scope 2 (market-based), and approximately 352.3 million kg CO2e from Scope 3 (value chain emissions). Previously, in 2024, Centrient Pharmaceuticals reported total emissions of approximately 697.0 million kg CO2e, with Scope 1 contributing about 142.9 million kg CO2e and Scope 2 (market-based) approximately 118.1 million kg CO2e. Scope 3 emissions in 2024 were around 436.1 million kg CO2e, with purchased goods and services being the largest contributor within this scope. The company has established ambitious climate commitments. Centrient Pharmaceuticals aims for an absolute reduction in Scope 1 and 2 GHG emissions of 46.2% by 2031, using 2022 as the base year. Furthermore, the company has committed to reducing absolute Scope 3 GHG emissions from purchased goods and services and fuel and energy-related activities by 27.5% within the same timeframe. These targets are aligned with keeping global warming to 1.5°C. Earlier targets included a 35% reduction in carbon emission intensity by 2025 and 50% by 2030, using 2015 as a baseline.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Centrient Pharmaceuticals’s Climate Goals (2030 & 2050)
3 goals2025
35% reduction in all scopes
35% reduction in carbon emission intensity (2025) and 50% by 2030*
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 3 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
10 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives

Science Based Targets Initiative

Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsFrequently asked questions
Common questions about Centrient Pharmaceuticals’s sustainability data and climate commitments
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project